A case of platelet and white blood cell reduction associated with pioglitazone and fenofibrate-Reference-Cited by-同舟云学术

A case of platelet and white blood cell reduction associated with pioglitazone and fenofibrate

Published:2014-02-01 Issue:3 Volume:5 Page:202-205
ISSN:2190-1678
Container-title:Diabetology International
language:en
Short-container-title:Diabetol Int

Author:

Inazawa Takeshi

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://link.springer.com/content/pdf/10.1007/s13340-014-0157-z.pdf

Reference23 articles.

1. Kaneko T, Baba S, Toyota T, et al. Clinical Effect of insulin-resistance-improving agent AD-4833 on patients of non-insulin-dependent diabetes mellitus treated with diet therapy. Rinsho Kenkyu. 1997;74:1227–49.

2. Kaneko T, Baba S, Toyota T, et al. Dose effect of insulin-resistance-improving agent AD-4833 on patients of non-insulin-dependent diabetes mellitus. Rinsho Kenkyu. 1997;74:1250–77.

3. Kaneko T, Baba S, Toyota T, et al. Dose effect of insulin-resistance-improving agent AD-4833 on patients of non-insulin-dependent diabetes mellitus treated with sulfonylurea. Rinsho Kenkyu. 1997;74:1278–306.

4. Kaneko T, Baba S, Toyota T, et al. Evaluation of insulin-resistance-improving agent AD-4833 on patients of non-insulin-dependent diabetes mellitus treated with diet therapy. Rinsho Kenkyu. 1997;74:1491–514.

5. Kaneko T, Baba S, Toyota T, et al. Evaluation of insulin-resistance-improving agent AD-4833 on patients of non-insulin-dependent diabetes mellitus treated with sulfonylurea. Rinsho Kenkyu. 1997;74:1515–39.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Four-Week Repeated Intravenous Dose Toxicity and Toxicokinetic Study of TS-DP2, a Novel Human Granulocyte Colony Stimulating Factor in Rats;Toxicological Research;2015-12-31

2. Fenofibrate/pioglitazone;Reactions Weekly;2015-01